Literature DB >> 26522096

Medical treatment for heavy menstrual bleeding.

Yi-Jen Chen1, Yiu-Tai Li2, Ben-Shian Huang3, Ming-Shyen Yen3, Bor-Ching Sheu4, Song-Nan Chow4, Peng-Hui Wang5.   

Abstract

Heavy menstrual bleeding, or menorrhagia, is subjectively defined as a "complaint of a large amount of bleeding during menstrual cycles that occurs over several consecutive cycles" and is objectively defined as menstrual blood loss of more than 80 mL per cycle that is associated with an anemia status (defined as a hemoglobin level of <10 g/dL). During their reproductive age, more than 30% of women will complain of or experience a heavy amount of bleeding, which leads to a debilitating health outcome, including significantly reduced health-related quality of life, and a considerable economic burden on the health care system. Although surgical treatment might be the most important definite treatment, especially hysterectomy for those women who have finished bearing children, the uterus is still regarded as the regulator and controller of important physiological functions, a sexual organ, a source of energy and vitality, and a maintainer of youth and attractiveness. This has resulted in a modern trend in which women may reconsider the possibility of organ preservation. For women who wish to retain the uterus, medical treatment may be one of the best alternatives. In this review, recent trends in the management of women with heavy menstrual bleeding are discussed.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  HMB; antifibrinolytics; heavy menstrual bleeding; levonorgestrel-releasing intrauterine system; medical treatment

Mesh:

Substances:

Year:  2015        PMID: 26522096     DOI: 10.1016/j.tjog.2015.08.001

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  2 in total

1.  Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial.

Authors:  Fatemeh Yousefi; Maryam Kashanian; Ismail Nazem; Soodabeh Bioos; Omid Sadeghpour; Jale Aliasl; Fataneh Hashem-Dabaghian
Journal:  Avicenna J Phytomed       Date:  2020 Sep-Oct

2.  The association between subjective assessment of menstrual bleeding and measures of iron deficiency anemia in premenopausal African-American women: a cross-sectional study.

Authors:  Lia A Bernardi; Marissa S Ghant; Carolina Andrade; Hannah Recht; Erica E Marsh
Journal:  BMC Womens Health       Date:  2016-08-15       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.